99mTc-labeling of Peptidomimetic Antagonist to Selectively Target v&bgr;3 Receptor-Positive Tumor: Comparison of PDA and EDDA as Co-Ligands

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|3|1|1-8

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.3, Iss.1, 2010-01, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Influence of Co-Ligands on Improving Tumor Targeting of 99mTc-HYNIC Conjugated Peptides

By  

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 2, 2017-01 ,pp. : 86-94

Bentham Science Publishers

Access to resources Recommend Favorite

Multimodality Imaging of Tumor Integrin v&bgr;3 Expression

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-02 ,pp. : 227-233

Bentham Science Publishers

Access to resources Recommend Favorite

In vitro evaluation of 99mTc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines

By Yurt Lambrecht Fatma   Durkan Kübra   Özgür Aykut   Gündüz Cumhur   Avcı Çığır Biray   Susluer Sunde Yılmaz  

Journal of Drug Targeting, Vol. 21, Iss. 4, 2013-05 ,pp. : 383-388

Informa Healthcare

Access to resources Recommend Favorite

Biological Evaluation of 99mTc-HYNIC-EDDA/tricine-(Ser)3-D4 Peptide for Tumor Targeting

By  

Current Radiopharmaceuticals, Vol. 10, Iss. 2, 2017-08 ,pp. : 123-130

Bentham Science Publishers

Access to resources Recommend Favorite

Ligands to the integrin receptor v&bgr;3

By Duggan M.E.   Hutchinson J.H.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 9, 2000-09 ,pp. : 1367-1383

Informa Healthcare

Access to resources Recommend Favorite